Cargando…

The Role of Angiotensin Antagonism in Coronary Plaque Regression: Insights from the Glagovian Model

The benefit of antagonizing the effect of the renin angiotensin aldosterone system (RAAS), notably by the use of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin II type 1 receptor blocker (ARB) for coronary artery disease (CAD), has been demonstrated in multiple studies, which may be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkatiri, Abdul H., Firman, Doni, Alkatiri, Amir A., Suryajaya, Paskalis I., Sudharsono, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046567/ https://www.ncbi.nlm.nih.gov/pubmed/33880191 http://dx.doi.org/10.1155/2021/8887248

Ejemplares similares

The effect of early dual antiplatelet timing on the microvascular resistance and ventricular function in primary percutaneous coronary intervention
por: Firman, Doni, et al.
Publicado: (2020)

Effect of thrombus aspiration on microcirculatory resistance and ventricular function in patients with high thrombus burden
por: Firman, Doni, et al.
Publicado: (2020)

Predicting multi-vascular diseases in patients with coronary artery disease
por: Adiarto, Suko, et al.
Publicado: (2023)

Comparison between radial versus femoral percutaneous coronary intervention access in Indonesian hospitals, 2017–2018: A prospective observational study of a national registry
por: Alkatiri, Amir Aziz, et al.
Publicado: (2020)

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2020)

Utility of Oral Quinine Sulfate for the Treatment of Brugada Syndrome Presenting as Electrical Storm in Remote Areas: Resilience in the COVID-19 Era
por: Amir, Muzakkir, et al.
Publicado: (2021)

Decrease in the Number of Patients Presenting With ST-Segment Elevation Myocardial Infarction Across Catheterization Centers in Indonesia During the Coronavirus Disease 2019 Pandemic
por: Firman, Doni, et al.
Publicado: (2021)

Clinical significance of bendopnea in heart failure—Systematic review and meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2019)

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)
por: Sukmawan, Renan, et al.
Publicado: (2021)

Characteristics and the average 30-day and 6-month clinical outcomes of patients hospitalised with coronary artery disease in a poor South-East Asian setting: the first cohort from Makassar Cardiac Center, Indonesia
por: Qanitha, Andriany, et al.
Publicado: (2018)

COVID-19 concomitant with infective endocarditis: A case report and review of management
por: Amir, Muzakkir, et al.
Publicado: (2020)

Role of Matrix Metalloproteinase Activity in the Neurovascular Protective Effects of Angiotensin Antagonism
por: Ishrat, Tauheed, et al.
Publicado: (2014)

Plaque regression and plaque stabilisation in cardiovascular diseases
por: Dave, Tarun, et al.
Publicado: (2013)

Impact of combined plaque structural stress and wall shear stress on coronary plaque progression, regression, and changes in composition
por: Costopoulos, Charis, et al.
Publicado: (2019)

Rare case of proximal coronary plaque regression after distal arterial grafting
por: Valooran, George Jose, et al.
Publicado: (2016)

C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV
por: Nelson, Adam J., et al.
Publicado: (2020)

Coronary Plaque Sampling Reveals Molecular Insights Into Coronary Artery Disease
por: Widlansky, Michael E., et al.
Publicado: (2023)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Regression and Stabilization of Coronary Vulnerable Plaque by Evolocumab as Assessed by Multidetector Row Computed Tomography
por: Shiga, Yuhei, et al.
Publicado: (2020)

The Effects of Statin and Niacin on Plaque Stability, Plaque Regression, Inflammation and Oxidative Stress in Patients With Mild to Moderate Coronary Artery Stenosis
por: Lee, Kyounghoon, et al.
Publicado: (2011)

Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial
por: Nakano, Yasuhiro, et al.
Publicado: (2023)

Are Patients with Low Non-HDL Cholesterol “Non-responders” to Statin Therapy on Coronary Plaque Regression?
por: Koba, Shinji
Publicado: (2016)

Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels
por: Wakabayashi, Kohei, et al.
Publicado: (2016)

The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
por: Li, Yingrui, et al.
Publicado: (2021)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Antagonism of Bacteria from Dog Dental Plaque against Human Cariogenic Bacteria
por: Martins, Káthia Santana, et al.
Publicado: (2018)

The prevention and regression of atherosclerotic plaques: emerging treatments
por: Kalanuria, Atul Ashok, et al.
Publicado: (2012)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Plaque Calcification During Atherosclerosis Progression and Regression
por: Shioi, Atsushi, et al.
Publicado: (2018)

Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE
por: Buckler, Andrew J., et al.
Publicado: (2023)

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression
por: Masson, Walter, et al.
Publicado: (2015)

Angiotensin type 2 receptor antagonism as a new target to manage gout
por: Vieira, Thiago Neves, et al.
Publicado: (2022)

Inhibition of indoxyl sulfate-induced intrarenal renin-angiotensin system activation: targeting the aryl hydrocarbon receptor
por: Akbar, Muhammad Firman
Publicado: (2017)

Chronic miR‐29 antagonism promotes favorable plaque remodeling in atherosclerotic mice
por: Ulrich, Victoria, et al.
Publicado: (2016)

Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive
por: Huart, Antoine, et al.
Publicado: (2015)

Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury
por: Ventura, Davide, et al.
Publicado: (2021)

Newer Insights into the Biochemical Physiology of the Renin–Angiotensin System: Role of Angiotensin-(1-7), Angiotensin Converting Enzyme 2, and Angiotensin-(1-12)
por: Ferrario, Carlos M., et al.
Publicado: (2009)

Survival analysis of patients with rheumatic MS after PBMV compared with MVS in a low-to-middle-income country
por: Ambari, A. M., et al.
Publicado: (2019)

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
por: Gao, Wen-Qian, et al.
Publicado: (2014)

Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease
por: Welty, Francine K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kbp1nrfi14qtehaaappc6399qe